Award

Delivery Order #SPE2DR26FGJV9

Short-term Delivery Order for Xolair Autoinjectors to DMS Pharmaceutical Group

Buyer

Defense Logistics Agency

Award Amount

$10,484.64

Ceiling

$10,484.64

Awarded

March 16, 2026

Period of Performance

Mar 16, 2026 – Apr 06, 2026

Identifier

SPE2DR26FGJV9

NAICS

424210

This award is a delivery order contract issued under a broader indefinite delivery vehicle held by DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical products and services. The contract procures a specific pharmaceutical product, Xolair 300 MG/2 ML autoinjectors, intended to support the agency's healthcare needs. The contract is significant as it provides timely access to essential medications, thereby enhancing the agency's ability to respond to public health requirements. The scope of work includes the delivery of these specialized autoinjectors within a brief, defined period, demonstrating a focused procurement effort. The contract was awarded recently and is scheduled for completion within a few weeks. This delivery order is part of a larger long-term pharmaceutical supply agreement, ensuring consistent availability of critical pharmaceutical products. The award was conducted under the existing contract vehicle, implying a streamlined procurement process and likely competitive terms established in the base indefinite delivery vehicle.

Description

4571360619!XOLAIR 300 MG/2 ML AUTOINJECT 2ML

View original record